Literature DB >> 31306575

Intrinsic GTPase Activity of K-RAS Monitored by Native Mass Spectrometry.

Zahra Moghadamchargari1, Jamison Huddleston1, Mehdi Shirzadeh1, Xueyun Zheng1, David E Clemmer2, Frank M Raushel1, David H Russell1, Arthur Laganowsky1.   

Abstract

Mutations in RAS are associated with many different cancers and have been a therapeutic target for more than three decades. RAS cycles from an active to inactive state by both intrinsic and GTPase-activating protein (GAP)-stimulated hydrolysis. The activated enzyme interacts with downstream effectors, leading to tumor proliferation. Mutations in RAS associated with cancer are insensitive to GAP, and the rate of inactivation is limited to their intrinsic hydrolysis rate. Here, we use high-resolution native mass spectrometry (MS) to determine the kinetics and transition state thermodynamics of intrinsic hydrolysis for K-RAS and its oncogenic mutants. MS data reveal heterogeneity where both 2'-deoxy and 2'-hydroxy forms of GDP (guanosine diphosphate) and GTP (guanosine triphosphate) are bound to the recombinant enzyme. Intrinsic GTPase activity is directly monitored by the loss in mass of K-RAS bound to GTP, which corresponds to the release of phosphate. The rates determined from MS are in direct agreement with those measured using an established solution-based assay. Our results show that the transition state thermodynamics for the intrinsic GTPase activity of K-RAS is both enthalpically and entropically unfavorable. The oncogenic mutants G12C, Q61H, and G13D unexpectedly exhibit a 2'-deoxy GTP intrinsic hydrolysis rate higher than that for GTP.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31306575      PMCID: PMC7196336          DOI: 10.1021/acs.biochem.9b00532

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  72 in total

Review 1.  RAS oncogenes: the first 30 years.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2003-06       Impact factor: 60.716

Review 2.  Mass spectrometry based tools to investigate protein-ligand interactions for drug discovery.

Authors:  Kamila J Pacholarz; Rachel A Garlish; Richard J Taylor; Perdita E Barran
Journal:  Chem Soc Rev       Date:  2012-04-24       Impact factor: 54.564

Review 3.  The ras superfamily of small GTP-binding proteins.

Authors:  J Downward
Journal:  Trends Biochem Sci       Date:  1990-12       Impact factor: 13.807

4.  Hurdles and complexities of codon 13 KRAS mutations.

Authors:  Maria Pia Morelli; Scott Kopetz
Journal:  J Clin Oncol       Date:  2012-08-27       Impact factor: 44.544

Review 5.  Signal transduction pathways involving Ras. Mini review.

Authors:  L Wiesmüller; F Wittinghofer
Journal:  Cell Signal       Date:  1994-03       Impact factor: 4.315

6.  Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival.

Authors:  Matthias Drosten; Alma Dhawahir; Eleanor Y M Sum; Jelena Urosevic; Carmen G Lechuga; Luis M Esteban; Esther Castellano; Carmen Guerra; Eugenio Santos; Mariano Barbacid
Journal:  EMBO J       Date:  2010-02-11       Impact factor: 11.598

Review 7.  RAS oncogenes: weaving a tumorigenic web.

Authors:  Yuliya Pylayeva-Gupta; Elda Grabocka; Dafna Bar-Sagi
Journal:  Nat Rev Cancer       Date:  2011-10-13       Impact factor: 60.716

Review 8.  The guanine nucleotide-binding switch in three dimensions.

Authors:  I R Vetter; A Wittinghofer
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

9.  Topological Analysis of Transthyretin Disassembly Mechanism: Surface-Induced Dissociation Reveals Hidden Reaction Pathways.

Authors:  Mehdi Shirzadeh; Christopher D Boone; Arthur Laganowsky; David H Russell
Journal:  Anal Chem       Date:  2019-01-28       Impact factor: 6.986

Review 10.  Targeting RAS signalling pathways in cancer therapy.

Authors:  Julian Downward
Journal:  Nat Rev Cancer       Date:  2003-01       Impact factor: 60.716

View more
  11 in total

1.  Discovery of a Bicyclic Peptidyl Pan-Ras Inhibitor.

Authors:  Marina Buyanova; Shurui Cai; Jahan Cooper; Curran Rhodes; Heba Salim; Ashweta Sahni; Punit Upadhyaya; Rui Yang; Amar Sarkar; Na Li; Qi-En Wang; Dehua Pei
Journal:  J Med Chem       Date:  2021-08-20       Impact factor: 8.039

Review 2.  High-Resolution Native Mass Spectrometry.

Authors:  Sem Tamara; Maurits A den Boer; Albert J R Heck
Journal:  Chem Rev       Date:  2021-08-20       Impact factor: 72.087

Review 3.  Variable-Temperature Native Mass Spectrometry for Studies of Protein Folding, Stabilities, Assembly, and Molecular Interactions.

Authors:  Arthur Laganowsky; David E Clemmer; David H Russell
Journal:  Annu Rev Biophys       Date:  2021-12-21       Impact factor: 19.763

Review 4.  THE IMS PARADOX: A PERSPECTIVE ON STRUCTURAL ION MOBILITY-MASS SPECTROMETRY.

Authors:  Jacob W McCabe; Michael J Hebert; Mehdi Shirzadeh; Christopher S Mallis; Joanna K Denton; Thomas E Walker; David H Russell
Journal:  Mass Spectrom Rev       Date:  2020-07-01       Impact factor: 10.946

Review 5.  GLOBAL AND TARGETED PROFILING OF GTP-BINDING PROTEINS IN BIOLOGICAL SAMPLES BY MASS SPECTROMETRY.

Authors:  Ming Huang; Yinsheng Wang
Journal:  Mass Spectrom Rev       Date:  2020-06-10       Impact factor: 10.946

Review 6.  Approaches to Heterogeneity in Native Mass Spectrometry.

Authors:  Amber D Rolland; James S Prell
Journal:  Chem Rev       Date:  2021-09-01       Impact factor: 72.087

7.  Molecular assemblies of the catalytic domain of SOS with KRas and oncogenic mutants.

Authors:  Zahra Moghadamchargari; Mehdi Shirzadeh; Chang Liu; Samantha Schrecke; Charles Packianathan; David H Russell; Minglei Zhao; Arthur Laganowsky
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-23       Impact factor: 12.779

Review 8.  Scratching the surface: native mass spectrometry of peripheral membrane protein complexes.

Authors:  Cagla Sahin; Deseree J Reid; Michael T Marty; Michael Landreh
Journal:  Biochem Soc Trans       Date:  2020-04-29       Impact factor: 5.407

Review 9.  K-Ras prenylation as a potential anticancer target.

Authors:  Marcell Baranyi; László Buday; Balázs Hegedűs
Journal:  Cancer Metastasis Rev       Date:  2020-12       Impact factor: 9.264

10.  Overcoming Resistance to Drugs Targeting KRASG12C Mutation.

Authors:  Delong Jiao; Shengyu Yang
Journal:  Innovation (Camb)       Date:  2020-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.